Arkansas Legal Resource Navigator

20-16-2203. Definitions. [Effective January 1, 2020.]

Arkansas Code — all titles (historical 2020) · legal_authorities

20-16-2203. Definitions. [Effective January 1, 2020.]

20-16-2203. Definitions. [Effective January 1, 2020.] As used in this subchapter: (1)(A) “Destructive embryo research” means medical procedures, scientific or laboratory research, or other types of investigation that kill or injure the human embryo subject of the procedure or research. (B) “Destructive embryo research” does not include: (i) In vitro fertilization and accompanying embryo transfer to the body of a woman; (ii) Research in the use of nuclear transfer or other cloning techniques to produce molecules, deoxyribonucleic acid, cells other than human embryos, tissues, organs, plants, or animals other than humans; or (iii) Any diagnostic procedure that benefits the human embryo subject of the procedure or research while not imposing risks greater than those considered acceptable for other human research subjects; (2) “Embryo” means an organism of the species Homo sapiens from the single cell stage to eight (8) weeks of development that is derived by fertilization, parthenogenesis, human cloning, or any other means from one (1) or more human gametes or human diploid cells; (3) “Embryonic stem cell” means a stem cell obtained from an embryo of the species Homo sapiens; (4) “Human cloning” means human asexual reproduction accomplished by: (A) Introducing the genetic material from one (1) or more human somatic cells into a fertilized or unfertilized oocyte whose nuclear material has been removed or inactivated so as to produce a living organism, at any stage of development, that is genetically identical to an existing or previously existing human organism; (B) Artificially subdividing a human embryo at any time from the two-cell stage onward resulting in more than one (1) human organism; or (C) Introducing pluripotent stem cells from any source

Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-16-2203

Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.

Issuing source page ↗

Authority boundary: historical statutory source snapshot not current law.

Open the recorded source website ↗

Record provenance

Stable record: arkansas_code:legal_authorities:20-16-2203
Source file: gov.ar.code.title.20.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 3a1bdd8f373bac6743b082a73720c858379c0650d3f41f8791dd63cb0ecd3bdb

Source location: content.xml paragraph 14792

Stored source content

20-16-2203. Definitions. [Effective January 1, 2020.] As used in this subchapter: (1)(A) “Destructive embryo research” means medical procedures, scientific or laboratory research, or other types of investigation that kill or injure the human embryo subject of the procedure or research. (B) “Destructive embryo research” does not include: (i) In vitro fertilization and accompanying embryo transfer to the body of a woman; (ii) Research in the use of nuclear transfer or other cloning techniques to produce molecules, deoxyribonucleic acid, cells other than human embryos, tissues, organs, plants, or animals other than humans; or (iii) Any diagnostic procedure that benefits the human embryo subject of the procedure or research while not imposing risks greater than those considered acceptable for other human research subjects; (2) “Embryo” means an organism of the species Homo sapiens from the single cell stage to eight (8) weeks of development that is derived by fertilization, parthenogenesis, human cloning, or any other means from one (1) or more human gametes or human diploid cells; (3) “Embryonic stem cell” means a stem cell obtained from an embryo of the species Homo sapiens; (4) “Human cloning” means human asexual reproduction accomplished by: (A) Introducing the genetic material from one (1) or more human somatic cells into a fertilized or unfertilized oocyte whose nuclear material has been removed or inactivated so as to produce a living organism, at any stage of development, that is genetically identical to an existing or previously existing human organism; (B) Artificially subdividing a human embryo at any time from the two-cell stage onward resulting in more than one (1) human organism; or (C) Introducing pluripotent stem cells from any source into a human embryo or artificially manufactured human embryo or trophoblast under conditions where the introduced cells generate all or most of the body tissues of the developing organism; (5) “Public funds” means without limitation: (A) Moneys received or collected by the state or any official, department, division, agency, or educational or political subdivision of the state, including without limitation: (i) Moneys derived from federal, state, or local taxes; (ii) Gifts or grants from any source; (iii) Settlement of any claim or cause of action; (iv) Bond proceeds or investment income; (v) Federal grants or payments; or (vi) Intergovernmental transfers; and (B) Moneys received or controlled by an official, department, division, or agency of the state government or any educational or political subdivision of the state pursuant to an appropriation by the General Assembly; and (6) “Somatic cell” means a diploid cell, having a complete set of chromosomes, obtained or derived from a living or deceased human body at any stage of development.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

No explicit source connection was found. This does not mean there are no relevant authorities.